Researchers identified a pathway by which chronic hyperglycaemia reduces cell function
On Nov. 14, 2022, in a study published in Nature Communications, researchers discovered the pathway by which chronic…
On Nov. 14, 2022, in a study published in Nature Communications, researchers discovered the pathway by which chronic…
On Nov. 10, 2022, researchers from the Okinawa Institute of Science and Technology (OIST), in collaboration with K….
On Nov. 10, 2022, Pfizer and BioNTech announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine…
On Nov. 9, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On Nov. 8, 2022, Novavax announced topline results from its Phase 3 Boosting Trial for the SARS-CoV-2 rS…
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
On Nov. 5, 2022, the U.S. Department of Agriculture’s (USDA) Animal Plant Health Inspection Service (APHIS) confirmed the…
On Nov. 4, 2022, the U.S. Department of Agriculture’s (USDA) Animal Plant Health Inspection Service (APHIS) confirmed the…
On Nov. 4, 2022, Pfizer and BioNTech announced updated data from a Phase 2/3 clinical trial demonstrating a…
On Nov. 3, 2022, researchers have identified the specific mutations in the mpox virus that contribute to its…
On Nov. 3, 2022, the University of Missouri announced a $1.5 million gift from the Orthopedic Foundation for…
On Nov. 3, 2022, Health Canada authorized an adapted version of the Moderna Spikevax COVID-19 vaccine that targets…
On Nov. 2, 2022, AIM ImmunoTech announced that the U.S. Food and Drug Administration had granted Orphan Drug…
On Nov. 2, 2022, Hologic announced that it had been awarded a $19 million contract from the Biomedical…
On Nov. 1, 2022, the U.S. Department of Agriculture announced it was making $30 million in American Rescue…
On Nov. 1, 2022, Pfizer announced positive top-line data from the Phase 3 clinical trial (NCT04424316) MATISSE (MATernal…
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
On Nov. 1, 2022, study results published in JAMA found that estimates in this cross-sectional study of 694,660…
On Oct. 31, 2022, the National Institutes of Health announced that a clinical trial had found that one…
On Oct. 31, 2022, Moderna announced that it had received approval from the Ministry of Health, Labour and…
On Sept. 3, 2014, The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,…
On Oct. 27, 2022, Inovio Pharma announced that it has discontinued its internally funded efforts to develop INO-4800…
On Oct. 27, 2022, the U.S. Department of Agriculture’s Animal Plant Health Inspection Service (APHIS) confirmed the presence…
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
On Oct. 27, 2022, the World Health Organization reported that an estimated 10.6 million people fell ill with…
On Oct. 26, 2022, the NIH announced it had awarded the University of Southern California (USC) $11.7 million…
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
On Oct. 25, 2022, Pacific Northwest National Laboratory (PNNL) announced that scientists have shown that they can detect…
On Oct. 25, 2022, the National Institutes of Health (NIH) announced that the University of Missouri had been…